Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
3.788
-0.060 (-1.56%)
At close: Apr 14, 2026, 4:00 PM EDT
3.800
+0.012 (0.32%)
After-hours: Apr 14, 2026, 7:05 PM EDT
Exicure Market Cap
Exicure has a market cap or net worth of $24.14 million as of April 14, 2026. Its market cap has decreased by -72.68% in one year.
Market Cap
24.14M
Enterprise Value
20.57M
1-Year Change
-72.68%
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since May 22, 2018, Exicure's market cap has decreased from $122.31M to $24.14M, a decrease of -80.26%. That is a compound annual growth rate of -18.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 24.14M | -30.11% |
| Dec 31, 2025 | 34.55M | -16.84% |
| Dec 31, 2024 | 41.54M | 727.79% |
| Dec 29, 2023 | 5.02M | -12.10% |
| Dec 30, 2022 | 5.71M | -72.06% |
| Dec 31, 2021 | 20.44M | -86.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 26.05M |
| Neuphoria Therapeutics | 25.77M |
| Boundless Bio | 25.32M |
| NeuroSense Therapeutics | 24.74M |
| Serina Therapeutics | 24.38M |
| Skye Bioscience | 24.03M |
| Tevogen Bio Holdings | 23.86M |
| Barinthus Biotherapeutics | 23.18M |